CHINASILVER TEC (00515) Receives Resumption Guidance from the Stock Exchange
China Silver Technologies (00515) announced that the company has received a letter dated December 18, 2025 from the Stock Exchange, which includes the following resumption guidelines applicable to the company: publish all unaudited financial performance as required by the Listing Rules and address any audit revisions; demonstrate compliance with Rule 13.24 of the Listing Rules; and disclose all material information to the market for shareholders and investors to evaluate the company's status.
CHINASILVER TEC (00515) announced that the company has received a letter from the Stock Exchange of Hong Kong dated December 18, 2025, listing the resumption guidance applicable to the company, including the publication of all unaudited financial performance as required by listing rules and handling any audit revisions; demonstrating compliance with Listing Rule 13.24; and disclosing all important information to the market for shareholders and investors to assess the company's condition.
The letter also states that the company must meet all resumption guidance, rectify the issues that led to the suspension of trading, and fully comply with the listing rules in order to be approved to resume trading of its securities. In this regard, the company is responsible for formulating its resumption action plan. The company's shares remain suspended.
Related Articles

US Stock Market Move | Partial encrypted mining enterprises concept fluctuated and rose. TeraWulf (WULF.US) surged nearly 5%.

US Stock Market Move | Fujian Eastern Red (ORIS.US) Soars Over 25% and Plans to Acquire Controlling Stake in Hubei Daguan Tea Industry Group.

US Stock Market Move | New antiemetic drug Nereus approved by FDA, Vanda Pharmaceuticals Inc. (VNDA.US) surges over 32%
US Stock Market Move | Partial encrypted mining enterprises concept fluctuated and rose. TeraWulf (WULF.US) surged nearly 5%.

US Stock Market Move | Fujian Eastern Red (ORIS.US) Soars Over 25% and Plans to Acquire Controlling Stake in Hubei Daguan Tea Industry Group.

US Stock Market Move | New antiemetic drug Nereus approved by FDA, Vanda Pharmaceuticals Inc. (VNDA.US) surges over 32%






